Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $67.7100 (0.18%) ($67.7100 - $68.0900) on Thu. Jul. 20, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.12% (three month average) | RSI | 18 | Latest Price | $67.7100(0.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.3% a day on average for past five trading days. | Weekly Trend | LGND declines -2.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(46%) IBB(43%) XHB(38%) UNG(36%) XAR(36%) | Factors Impacting LGND price | LGND will decline at least -1.06% in a week (0% probabilities). TBT(-22%) UUP(-21%) VXX(-18%) XLU(-11%) VIXM(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.06% (StdDev 2.12%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $62.83(-7.21%) | Resistance Level | $70.32 | 5 Day Moving Average | $67.94(-0.34%) | 10 Day Moving Average | $68.57(-1.25%) | 20 Day Moving Average | $70.32(-3.71%) | To recent high | -15% | To recent low | 0.2% | Market Cap | $1.088b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |